Vaxart

Youtube Subscribe

Open: 1.25 Close: 1.23 Change: -0.02

How to know if Vaxart Stock is a risky investment without reading the whole internet.

This document will help you to evaluate Vaxart without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, value, Vaxarts, stock, market, email, Exchange, and the …

Concept Map

Semantic Network

Stock Summary

Vaxart, Inc. engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase.

Today's Summary

Vaxart Inc. (VXRT) has 135,597,316 shares trading at $1.20 per share. The total value of the stock is $162.72M. The market value is measured differently than its book value.

Today's News

Vaxart sent this email to their subscribers on May 25, 2023. Text-only version of this email has been filed with the United States Securities and Exchange Commission. Vaxart reduces workforce and pauses COVID-19 vaccine development 20-Mar-2023. Vaxarts is trying to develop an oral pan-betacoronavirus vaccine. Vaxart Inc (VXRT) is traded on NASDAQ Exchange in USA. Vaxarts financial strength is of vital concern to both outside investors and internal stakeholders. Vaxart stock is mainly related to its market volatility and company specific events. When the price of a selected benchmark declines in a down market, there may be an uptick in Vaxarts stock price where buyers come in believing the asset is cheap. Vaxart Inc. (VXRT) has 135,597,316 shares trading at $1.20 per share, the total value of the stock is $162.72M. The market value is measured differently than its book value, which is the value that is recorded on the companys balance sheet.

Stock Profile

"Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California."

Keywords

Are looking for the most relevant information about Vaxart? Investor spend a lot of time searching for information to make investment decisions in Vaxart. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, value, Vaxarts, stock, market, email, Exchange, and the most common words in the summary are: therapeutic, vaxart, pharmaceutical, stock, inc, pharma, vxrt, . One of the sentences in the summary was: (VXRT) has 135,597,316 shares trading at $1.20 per share. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #vaxart #pharmaceutical #stock #inc #pharma #vxrt.

Read more →

Youtube Subscribe

---